Viewing Study NCT04707703

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2026-02-08 @ 12:14 AM
Study NCT ID: NCT04707703
Status: TERMINATED
Last Update Posted: 2022-11-25
First Post: 2021-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
Sponsor: Jeffrey Jenks, MD, MPH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Acute Respiratory Syndrome Coronavirus 2 View
None Aspergillosis Invasive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Isavuconazole View
None Antifungal Agents View
None Anti-infective Agents View
None Coronavirus-associated Invasive Pulmonary Aspergillosis View
None CAPA View